2023-11-14T13:44:56-06:00 2021-12-31 454060696 CCA LLP 2300 Contra Costa Blvd Pleasant Hill CA 94523 990 2021-01-01 943473864 Sens Foundation Inc SENS 6503361780 110 Pioneer Way J Mountain View CA 94041 Lisa Fabiny Executive Director 6503361780 2023-11-14 1 Lisa Fabiny 999009999 CCA LLP P00587987 9256852911 2023-11-13 3 AAL1 IAL1 2021 2023-04-26 12:10:37Z X Sens Research Foundation Inc Lisa Fabiny 110 Pioneer Way J Mountain View CA 94041 55348185 0 X www.sens.org X 2009 CA Develop, promote and ensure widespread access to rejuvenation biotechnologies. 9 8 38 8 30000 7976 3869522 29951590 75329 79439 21397 151247 36194 36590 4002442 30218866 662690 2592881 0 0 2252870 2835495 0 0 639908 1154541 2094804 4070101 7523180 -67659 22695686 3998305 28441155 601239 2358718 3397066 26082437 X SENS Research Foundation works to develop, promote, and ensure widespread access to therapies that cure and prevent the diseases and disabilities of aging by comprehensively repairing the damage that builds up in our bodies over time. We are redefining the way the world researches and treats age-related ill health, while inspiring the next generation of biomedical scientists. 0 0 1278770 The intramural research program is carried out in the Organization's Mountain View facility by employees of the Organization. The program is comprised of three (3) separate lines of research: Mitochondrial mutations, Immuno-senescence, and Stem Cell Therapy. The Mitochondrial mutations line of research has published work and has a few subprojects with outside institutions. The Immuno-senescence line of research project has also published work, is hiring new staff, and contains seven subprojects, one of which is run by a Post-Doctoral Fellow. The Stem Cell Therapy line of research has published work, including that of an international PhD Student from the United Kingdom. 2475944 2474381 The extramural research program funds some of the most prestigious institutions around the world. There are currently four (4) extramural research projects ongoing. Funding for this program continues to be prioritized for projects that meet our company mission and are currently being unaddressed in our intramural research program. 718336 118500 SRF Education - As part of its mission, the Organization is committed to educating students and the public about rejuvenation biotechnologies. The Organization's student program, SRF Education, is committed to educating students and the public. SRF Education operates a summer internship program that places twelve (12) undergraduate students at the SRF Research Center and outside institutions. It also continues a program to place nine (9) post-baccalaureate students at various institutions, including four (4) at the SRF Research Center. 2021 saw the expansion of SRF's Master's program in conjunction with Dominican University of California. SRF now has two (2) Master's students. 79838 Educational Conferences - In addition to participation in a variety of scientific and public engagements, the Organization organizes its own conferences and events. This outreach is intended to inform both the scientific community and the public about damage-repair strategies for improving healthcare. In person programs were cancelled in 2021 due to the COVID-19 pandemic. 1202370 86029 Other programs - The Organization conducts other programs related to the mission of the organization. 1282208 86029 5755258 1 1 0 0 0 0 0 0 0 0 1 0 0 0 1 1 1 0 0 0 0 1 0 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 1 16 0 1 38 1 1 1 0 0 0 0 0 0 0 0 0 0 0 X 9 8 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA X The Organization 6503361780 110 Pioneer Way J Mountain View CA 94041 Barbara Logan Chairperson 5.00 X X 0 0 0 Bill Liao Secretary 1.00 X X 0 0 0 Kevin Perrott Treasurer 1.00 X X 0 0 0 Kevin Dewalt Director 1.00 X 0 0 0 Frank Schuler Director 1.00 X 0 0 0 Michael Kope Director 1.00 X 0 0 0 Michael Boocher Director 1.00 X 0 0 0 Jonathan Cain Director 1.00 X 0 0 0 Jim O'Neill President/CEO 1.00 X X 441610 0 15187 Lisa Fabiny-Kiser Acting Executive Director 40.00 X 176720 0 44378 Alexandra Stolzing VP Research 40.00 X 158105 0 9536 Gregory Chin Director of Education 40.00 X 126289 0 12969 Maria Entraigues Director of Outreach 40.00 X 116545 0 21576 Amutha Boominathan Group Lead, MitoSENS 40.00 X 107272 0 2393 Amit Sharma Group Lead, Apopto 40.00 X 102432 0 29144 1228973 0 135183 7 0 1 0 Littler Mendelson PC 2301 McGee Street Kansas City MO 64108 Legal Services 276230 Van Dermyden Makus Law Corporation 2520 Venture Oaks Way Suite 450 Sacramento CA 95833 Legal and Consulting Services 126123 2 332795 29618795 23905544 29951590 Sublease income 532000 79439 79439 79439 21104 21104 1561356 23698106 1547219 23582100 14137 116006 130143 130143 Resource-sharing income 900002 30000 30000 Program-related sales 900099 4910 4910 Miscellaneous income 900099 1680 1680 36590 30218866 86029 30000 151247 2250010 2250010 76500 76500 266371 266371 777635 264219 230658 282758 1608342 1395848 64450 148044 30251 23506 5074 1671 246895 186276 29942 30677 172372 126854 19691 25827 460734 17180 443554 75496 52592 10025 12879 702695 494098 192481 16116 5689 5187 502 10003 40 9963 271952 240523 22046 9383 17140 15564 886 690 16745 16745 44513 31658 12855 15406 15406 UBI taxes 2013 2013 Equipment and supplies 270182 270182 Bank service fees 124358 97 13131 111130 Small computer equipmen 39758 9394 30364 38120 12414 24973 733 7523180 5755258 1128014 639908 3441772 27966946 101376 0 31149 51784 983810 685991 70607 297819 13269 1232 255760 54510 84372 68864 3998305 28441155 262962 353236 2000000 338277 5482 601239 2358718 X 3284492 25158373 112574 924064 3397066 26082437 3998305 28441155 22695686 -10315 0 X X 0 1 X 1 0 X 7840321 3531916 2589086 3869523 29951591 47782437 7840321 3531916 2589086 3869523 29951591 47782437 8473061 39309376 28016 2478 4279 21397 152012 208182 47990619 282819 0.81910 0.57300 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 741259 454751 286508 242551 231240 11311 297819 Security deposit 5482 5482 X 30208551 -10315 -10315 30218866 0 30218866 7523180 0 7523180 0 7523180 Part X, Line 2: The Organization evaluates its uncertain tax positions and will recognize a loss contingency when it is probable that a liability has been incurred as of the date of the financial statements and the amount of the loss can be reasonably estimated. The amount recognized is subject to estimate and management judgment with respect to the likely outcome of each uncertain tax position. The amount that is ultimately sustained for an individual uncertain tax position or for all uncertain tax positions in the aggregate could differ from the amount recognized. As of December 31, 2021, management did not identify any uncertain tax positions. 1 0 0 0 0 0 0 0 0 0 Epinal Way Loughborough LE11 3TU United Kingdom Extramural research grant 53571 Wire 0 Arthur-Scheunert-Allee 114-116 Nuthetal 14558 Germany Extramural research grant 212800 Wire 0 2 0 0 0 0 0 0 Part III Accounting Method: 1 Albert Einstein College of Medicine 1300 Morris Park Ave The Bronx NY 10461 131624225 501c3 208010 0 Extramural research grant Buck Institute for Research on Aging 8001 Redwood Blvd Novato CA 94945 943030609 501c3 21000 0 Educational intern grant Sanford-Burnham Medical Research Inst 10901 N Torrey Pines Rd La Jolla CA 92037 510197108 501c3 10000 0 Educational intern grant Dominican University of California 50 Acacia Avenue San Rafael CA 94901 941156525 501c3 10000 0 Educational intern grant for Master's student Methuselah Foundation 8021 Flint St Springfield VA 22153 542040344 501c3 2000000 0 Extramural research grant 5 Research grants 10 76500 Part I, Line 2: The Organization monitors grants at three month intervals. We require interim research reports every three months, which are submitted with the next payment invoice. At the conclusion of each research contract, we require a comprehensive research report and a financial accounting that details how the grant was spent. X X 0 0 0 0 0 0 0 0 0 Jim O'Neill President/CEO 441610 0 0 0 0 0 0 0 15187 0 456797 0 0 0 Lisa Fabiny-Kiser Acting Executive Director 176720 0 0 0 0 0 5338 0 39040 0 221098 0 0 0 Alexandra Stolzing VP Research 158105 0 0 0 0 0 0 0 9536 0 167641 0 0 0 X 808423 1535149 FMV X Crypto currency 18795014 22370396 FMV 8 0 0 0 Part I, Column (b): Number of units received Form 990 Section B - Return Amendment Upon completion of 2021 audited financial statements, it was determined that on GAAP basis, a $2M grant should have been recognized in 2021 rather than in 2022. As a result, the following areas of the return were amended for the corresponding amount: Statement of Program Service Accomplishments Part III Increase in total expenses and grant expenses listed on line 4b Statement of Functional Expenses Part IX Increase in grant expenses Balance Sheet Part X Increase in grants payable Reconciliation of Net Assets Part XI Increase in total expenses Schedule D Part XII Increase in total expenses Schedule I Part II Additional grant recipient listed Form 990, Part VI, Section B, line 11b The form 990 is reviewed by the Executive Director and presented to the Board prior to filing. Form 990, Part VI, Section B, line 12c A formal conflict of interest policy has been adopted by the organization. The policy is reviewed and reaffirmed annually. Form 990, Part VI, Section B, line 15 The officer salaries are determined through the budget process by the board of directors. The board used comparable data for determining salaries of all key employees. Form 990, Part VI, Section C, line 18 The forms 1023 and 990 are available at the organization's offices upon request. Form 990, Part VI, Section C, line 19 All governing documents, the conflict of interest policy and the financial statements are available at the organization's offices upon request Form 990, Part XII, Line 2c The Organization's audit committee is charged with the responsibility of overseeing the audit and the work of the independent auditors. This process has not changed from prior years.